ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,263, issued on Feb. 25, was assigned to Avent Inc. (Alpharetta, Ga.).

"Device and method to modulate a nervous system structure to non-invasively and non-destructively inhibit nervous signaling" was invented by David M. Page (Alpharetta, Ga.), Eric A. Schepis (Alpharetta, Ga.), Jalpa Shah (Alpharetta, Ga.) and Natalia Alexeeva (Alpharetta, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to a system and method modulating targeted neural and non-neural tissue of a nervous system for the treatment of head-and-face pain. Electrical stimulation is delivered transcutaneously to the treatment site that modulates the ta...